Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma

British Journal of Radiology

Volumn 85, Issue 1018, 2012, Pages

  Jones, Bleddyn ^a,b   Wilson, P ^b   Nagano, A ^b   Fenwick, J ^b   Mckenna, G ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; BRAIN; BRAIN TISSUE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CARDIOVASCULAR DISEASE; CELL GROWTH; CENTRAL NERVOUS SYSTEM; CHILD; CONTROLLED STUDY; HUMAN; MEDULLOBLASTOMA; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION INDUCED NEOPLASM; RELATIVE BIOLOGIC EFFECTIVENESS; SCHOOL CHILD; SPINAL CORD; TUMOR CELL; TUMOR RECURRENCE; X RAY;

EID: 84866843250     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/24498486     Document Type: Article

References (21)

1. Yock T, DeLaney TF, Esty B, Tarbell NJ. Pediatric tumours. In: Proton and charged particle radiotherapy. Delaney TF, Kooy HM, eds. Philadelphia, PA: Lippincott, Williams and Wilkins; 2008. pp. 125-30.
2. Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362-72. (Pubitemid 41317152)
3. St Clair WH, Adams JA, Bues M, Fullerton BC, La Shell S, Kooy HM, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004;58:727-34. (Pubitemid 38221128)
4. Cochran DM, Yock TI, Adams JA, Tarbell NJ. Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Int J Radiat Oncol Biol Phys 2008;70:1336-42. (Pubitemid 351417754)
5. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
6. Advisory Group on Ionising Radiation. Circulatory disease risk. London, UK: Health Protection Agency; 2010.
7. Paganetti H, Gerweck LE, Goitein M. The general relation between tissue response to X-radiation (a/b values) and the relative biological effectiveness (RBE) of protons: prediction by the Katz track structure model. Int J Radiat Biol 2000;76: 985-98. (Pubitemid 30446962)
8. Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21. (Pubitemid 34522107)
9. Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413-26. (Pubitemid 37362998)
10. Wouters BG, Lam GK, Oelfke U, Gardey K, Durand RE, Skarsgard LD. Measurements of relative biological effectiveness of the 70MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay. Radiat Res 1996;146:159-70. (Pubitemid 26262043)
11. Belli M, Bettega D, Calzolari P, Cera F, Cherubini R, Dalla Vecchia M, et al. Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol 2000;76:831-9. (Pubitemid 30352767)
12. Hawkins RB. A microdosimetric-kinetic model for the effect of non-Poisson distribution of lethal lesions on the variation of RBE with LET. Radiat Res 2003;160:61-6.
13. Jones B, Underwood TSA, Carabe-Fernandez A, Timlin C, Dale RG. Fast neutron relative biological effects and implications for charged particle therapy. Br J Radiol 2011;84:S11-18.
14. Wigg DR. Applied radiobiology. Madison, WI: Medical Physics Publishing; 2008. p. 216.
15. Jones B. The apparent increase in the b-parameter of the linear quadratic model with increased linear energy transfer during particle irradiation. Brit J Radiol 2010;83: 433-6.
16. Barazzuol L, Burnet NG, Jena R, Jones B, Jefferies SJ, Kirkby NF. A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects. J Theor Biol 2010;262:553-65.
17. Higgins GS, Prevo R, Lee Y-F, Helleday T, Muschel RJ, Taylor S, et al. A siRNA screen of genes involved in DNA repair identifies tumour specific radiosensitisation by POLQ knockdown. Cancer Res 2010;70:2984-93.
18. Halperin EC. Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys 1996;36:233-9. (Pubitemid 26314171)
19. del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, et al. Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 1998;42:147-54. (Pubitemid 28435607)
20. Royal College of Radiologists. The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions. 3rd edn. London, UK: Royal College of Radiologists; 2008.
21. Jones B, Carabe-Fernandez A, Dale RG. Calculation of high- LET radiotherapy dose required for compensation of overall treatment time extensions. Brit J Radiol 2006;79:254-7.